Literature DB >> 2408663

Primary structure of papain-solubilized human histocompatibility antigen HLA-B27.

A Ezquerra, R Bragado, M A Vega, J L Strominger, J Woody, J A López de Castro.   

Abstract

The complete amino acid sequence of papain-solubilized HLA-B27, an antigen that presents a very strong association to the development of ankylosing spondylitis, has been determined. The overall sequence homology with the cross-reactive allelic products HLA-B7 and HLA-B40 (Bw60) is 93% and 92%, respectively. Half of the differences between HLA-B27 and -B7 are located in segments 63-83 and 113-116. Most of the known HLA class I antigens are different in these segments, and it is suggested that the corresponding residues may be involved in the alloantigenic determinants of HLA-B27. A free cysteine residue is present at position 67, and it is at least partially exposed to solvent. In addition, other differences are found in various areas of the two N-terminal domains. The comparison with available HLA class I sequences allows an evaluation of their contribution to the antigenic polymorphism of these molecules. The relevance of these data is discussed in connection with the mapping of functional sites of HLA class I antigens and with the association between HLA-B27 and ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408663     DOI: 10.1021/bi00328a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

Review 1.  HLA-B27 subtypes: implications for the spondyloarthropathies.

Authors:  L MacLean
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

2.  Molecular typing of HLA-B27 alleles.

Authors:  O Dominguez; E Coto; E Martinez-Naves; S Y Choo; C López-Larrea
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.

Authors:  M A Vega; A Ezquerra; S Rojo; P Aparicio; R Bragado; J A López de Castro
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.

Authors:  E P Cowan; M L Jelachich; W E Biddison; J E Coligan
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  A transposable epitope of HLA-B7, B40 molecules.

Authors:  J P Ways; D A Lawlor; A M Wan; P Parham
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.

Authors:  B S Breur-Vriesendorp; A J Dekker-Saeys; P Ivanyi
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

7.  Molecular cloning and partial nucleotide sequence of a 3.5 kb HLA-B27-associated fragment of genomic DNA.

Authors:  J A Trapani; C A Mickelson; N J Deacon; D J Hooker; I F McKenzie
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  Transfection of murine LMTK- cells with purified HLA class I genes. VII. Association of allele- and locus-specific serological reactivities with respectively the first and second domains of the HLA-B7 molecule.

Authors:  R Sodoyer; B Kahn-Perles; T Strachan; J Sire; M J Santoni; C Layet; P Ferrier; B R Jordan; F A Lemonnier
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  A new public antigen shared by all HLA-A locus products except HLA-A23, -A24, -A32, and -A25 is probably influenced by the amino acid residue at position 79 in the alpha 1 domain.

Authors:  L P de Waal; C van der Meer; A R van der Horst; F H van der Velde
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series.

Authors:  H Szöts; G Riethmüller; E Weiss; T Meo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.